Putting it All Together in Bipolar Disorder: Novel Treatment Options Focused on the Whole Patient

This Master Class session aims to equip participants with the knowledge and skills to better understand the diagnostic challenges associated with bipolar disorder (BD), including differentiating BD1, BD2, and MDD. Expert faculty will highlight the impact of cardiometabolic burden on treatment adherence and overall outcomes in patients with BD, providing practical guidance on how to mitigate these risks. Participants will also be introduced to the limitations of traditional antipsychotic agents and off-label therapies in BD, as well as the latest clinical evidence and mechanisms of action associated with newer/novel therapies. The session will conclude by evaluating the potential of these newer/novel therapies to mitigate cardiometabolic adverse effects in patients with BD, equipping participants to make informed decisions about which therapy to prescribe in individual cases.

Supported by an independent educational grant from Intra-Cellular Therapies, Inc.